Data Privacy Statement

On this page we provide information about our handling of personal data in connection with this website (1. General Privacy Notice) and when adverse reports are reported (2. Privacy Notice for Pharmacovigilance)

 

1. General Privacy Notice

This data privacy statement explain how Boehringer Ingelheim International GmbH (hereafter "Boehringer Ingelheim", "we", "us") processes which personal data of you for which purposes. In any event, collection and processing of personal data will only take place conformable to the applicable law (i.e. the General Data Protection Regulation, "GDPR").

Contact form or other requests

We process your data in order to provide you with the agreed or requested services on this website:

• If you register and log in;
• if you take part in training courses or events;
• if you send us inquiries about products or possible adverse event.

The legal basis is Article 6 (1) b) GDPR. 

Log data

1. Log data and technical cookies
When using the website, certain data, including data sent by the browser (e.g. IP address, cookies, previous website, time and date, displayed contents) is temporarily stored. We use this data to enable you to use our website and, if necessary, to review and assert our and third party rights in the event of damage or violations of legal regulations, our terms of use and the rights of third parties. The legal basis is Article 6 (1) f) GDPR. 

We use cookies and similar technologies such as pixel tags, web beacons and clear GIFs (hereinafter referred to as "cookies"). We use cookies for technical reasons, such as to resume a user's session when logging in if the previous session was interrupted due to inactivity. These cookies are not used to analyse the use of our website. The legal basis is Article 6 (1) f) GDPR.

2. Analytics
Adobe Analytics (Omniture)

We also use cookies from Adobe Analytics, a web analytics service provided by Adobe Systems Software Ireland Limited ("Adobe"). Adobe Analytics uses cookies on behalf of Boehringer Ingelheim to analyze all traffic and usage patterns. The IP address collected by the cookies is made anonymous before it is geolocated. In addition, it is replaced by a generic IP address. Adobe will not associate your IP address with other information held by Adobe. You can prevent Adobe from collecting and using information (cookies and IP address) by using your options at http://www.adobe.com/privacy/opt-out.html As data can be transferred to the USA in exceptional cases, Adobe is self-certified itself to the EU-U.S. Privacy Shield.
The analyses help us to improve our services. The legal basis is Article 6 (1) f) GDPR.

Data Transfer to Third Parties

We may share personal information with third parties.

1. Reporting obligations to regulatory authorities and enforcement of rights
As a pharmaceutical company, we are subject to specific regulations, such as pharmacovigilance. Some of these laws require us to send your reports to regulators or other authorities worldwide (including countries that may have a different level of data protection than the EU). We only provide authorities with personal data if we are legally obliged to do so.
In order to protect our rights or the rights of third parties, we may also disclose data to rights holders, consultants and authorities in accordance with legal provisions.

2. Service provider
We engage service providers to process your personal data for the purposes described in this data protection information. These service providers process the data only on our behalf, in accordance with our instructions and under our control in accordance with this data privacy declaration.

One of these service providers is Adobe Systems Software Ireland Limited, 4-6 River-walk, Citywest Business Campus, Dublin 24, Ireland, providing data and web analytics services.

3. Boehringer Ingelheim companies
As part of a global group of companies, we involve other Boehringer Ingelheim companies that support us in data processing. These group companies process the data exclusively for the purposes stated in this data protection declaration.

4. Data transfer to recipients outside the EU
Some of these service providers and Boehringer companies process personal data outside the EU. In these cases, we ensure an adequate level of data protection to comply with European law (usually through EU standard contractual clauses published by the European Commission).

Deletion

Boehringer Ingelheim processes your personal data for as long as necessary for the purpose of the processing, which mainly is the provision of our services requested by you. This means for example that we send you newsletters for as long as you did not withdraw your subscription or that we store your user account data (login, profession, name etc.) for as long as you maintain a user account with us.

We will retain personal information for as long as necessary for the particular business purpose or purposes for which it was collected. If you revoke your consent, delete user accounts or object to data processing, we will delete the data collected in a timely manner. 

In some cases we are obliged to keep data to comply with statutory retention periods (e.g. in the context of pharmacovigilance). In such a case, we will ensure that your data will only be used to comply with the retention obligations and not for other purposes.

Your Rights

You can request information which personal data we store. If you have provided personal data based on a contract or consent, you have the right to receive this data in a common and machine-readable format.
In justified cases, you may also request the deletion, correction or limitation of the processing of your data. If your personal data is transferred to a country outside the EU that does not provide adequate protection, you may request a copy of the contract that provides adequate protection of personal data.

Where you provided consent for the use of your personal data, you can withdraw your consent at any time with future effect.

If we use your personal data on the basis of a balance of interests, you can object to the use of your data. In this case, we will no longer use your data unless our interests prevail. You can object to the use of your data for direct marketing purposes, e.g. the receipt of mailings, at any time without further consideration.

Contact

If you have any questions about our use of personal data, this data protection declaration or would like to exercise your rights, you can contact us at any time or you can contact our data protection officer directly:

Boehringer Ingelheim International GmbH
– Data Protection Officer –
Binger Straße 173
D-55216 Ingelheim am Rhein
Germany

E-mail: datenschutz@boehringer-ingelheim.com

In case of questions or concerns you can also contact the competent data protection authority (especially where you live or where we are established).

Data privacy statement as of: May 16, 2018

 

 

2. Privacy Notice for Pharmacovigilance

Purpose of the data collection

Thank you for reporting adverse events or other pharmacovigilance relevant information to a Boehringer Ingelheim product to Boehringer Ingelheim Pharma GmbH & Co KG, Binger Straße 173, 55216 Ingelheim am Rhein. Your report is very important for public health. We will use and share this data solely for pharmacovigilance purposes. (Pharmacovigilance is the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.) 

Handling of the report (sharing with Boehringer Ingelheim companies and authorities)

Boehringer Ingelheim Pharma GmbH & Co KG will share the report with Boehringer Ingelheim International GmbH who is operating the global pharmacovigilance database. 
Boehringer Ingelheim is obliged to report pharmacovigilance relevant information to health authorities worldwide (including to countries that may have another level of data protection compared to the EU).¹ The reports will contain details about the incident but only limited personal data:

• For Patients, the report will only contain, [age / date of birth / year of birth], gender and initials as provided, but never the patient's name.  
• For the reporting individuals, the report will include the name, profession (e.g. physician, pharmacist), initials or address, email and phone number as provided. The contact information is required to be able to follow-up with the reporter to gain high quality and complete information on adverse events. If the reporter does not wish to provide his contact details to Boehringer Ingelheim or authorities, “Privacy” is entered in reporter's names field.

Where your data is shared with other Boehringer Ingelheim companies, business partners or service providers outside of the EU, we will provide an adequate protection of personal data.

Retention period

As reports about adverse events are important for public health reasons, reports are kept for minimum of 10 years after withdrawal of the product in the last country where the product is marketed.  

Information requests about the handling of your personal data

Upon your request, we will inform you which data we store about you for which purposes. In justified cases, you may also request the deletion, correction or limitation of the processing of your personal data. 

You may also object to the processing of your personal data for the transfer to authorities outside the EU described above unless the interests of Boehringer Ingelheim prevail.

If your personal data is transferred to a country outside the EU which does not provide appropriate protection, you can request a copy of the contract that implements the appropriate protection of personal data. Please send your request to:

Datenschutz@Boehringer-Ingelheim.com

In addition and in case of concerns, you can also contact the competent data protection authority: Der Landesbeauftragte für den Datenschutz und die Informationsfreiheit Rheinland-Pfalz, Hintere Bleiche 34, 55116 Mainz, poststelle@datenschutz.rlp.de.